RTL1
geneOn this page
Also known as PEG11MART1Mar1SIRH2HUR1
Summary
RTL1 (retrotransposon Gag like 1, HGNC:14665) is a protein-coding gene on chromosome 14q32.2, encoding Retrotransposon-like protein 1 (A6NKG5). Plays an essential role in capillaries endothelial cells for the maintenance of feto-maternal interface and for development of the placenta.
This gene is a retrotransposon-derived, paternally expressed imprinted gene that is highly expressed at the late fetal stage in both the fetus and placenta. It has an overlapping maternally expressed antisense transcript, which contains several microRNAs targeting the transcripts of this gene through an RNA interference (RNAi) mechanism. This gene is essential for maintenance of the fetal capillaries.
Source: NCBI Gene 388015 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 219 total
- Phenotypes (HPO): 169
- MANE Select transcript:
NM_001134888
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14665 |
| Approved symbol | RTL1 |
| Name | retrotransposon Gag like 1 |
| Location | 14q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PEG11, MART1, Mar1, SIRH2, HUR1 |
| Ensembl gene | ENSG00000254656 |
| Ensembl biotype | protein_coding |
| OMIM | 611896 |
| Entrez | 388015 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000649591
RefSeq mRNA: 2 — MANE Select: NM_001134888
NM_001134888, NM_001425285
CCDS: CCDS53910
Canonical transcript exons
ENST00000649591 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003832034 | 100879753 | 100884874 |
| ENSE00003836409 | 100903605 | 100903722 |
| ENSE00003839549 | 100903291 | 100903386 |
| ENSE00003840561 | 100893444 | 100893505 |
Expression profiles
Bgee: expression breadth broad, 44 present calls, max score 81.61.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1118 / max 81.8391, expressed in 26 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144955 | 0.1118 | 26 |
Top tissues by expression
104 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 81.61 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.39 | silver quality |
| placenta | UBERON:0001987 | 72.13 | gold quality |
| hypothalamus | UBERON:0001898 | 66.05 | gold quality |
| sural nerve | UBERON:0015488 | 64.29 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 58.66 | silver quality |
| colonic epithelium | UBERON:0000397 | 58.02 | gold quality |
| adrenal gland | UBERON:0002369 | 54.07 | gold quality |
| substantia nigra | UBERON:0002038 | 53.59 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 52.16 | gold quality |
| left ovary | UBERON:0002119 | 51.62 | gold quality |
| right adrenal gland | UBERON:0001233 | 51.56 | gold quality |
| ovary | UBERON:0000992 | 51.19 | gold quality |
| stromal cell of endometrium | CL:0002255 | 50.38 | silver quality |
| right ovary | UBERON:0002118 | 50.18 | gold quality |
| left adrenal gland | UBERON:0001234 | 49.75 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 49.28 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 48.05 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 47.71 | gold quality |
| muscle tissue | UBERON:0002385 | 46.41 | gold quality |
| nucleus accumbens | UBERON:0001882 | 46.14 | gold quality |
| gall bladder | UBERON:0002110 | 44.51 | silver quality |
| temporal lobe | UBERON:0001871 | 43.81 | gold quality |
| amygdala | UBERON:0001876 | 43.66 | gold quality |
| primary visual cortex | UBERON:0002436 | 43.16 | gold quality |
| tonsil | UBERON:0002372 | 42.62 | silver quality |
| brain | UBERON:0000955 | 42.35 | gold quality |
| islet of Langerhans | UBERON:0000006 | 42.28 | silver quality |
| adenohypophysis | UBERON:0002196 | 41.63 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 41.41 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.62 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NEUROG2
Literature-anchored findings (GeneRIF, showing 7)
- RTL1, a paternally expressed gene in a cluster of imprinted genes on chromosome 14q32.2, is associated with upd(14)pat-like and upd(14)mat-like phenotypes. (PMID:18176563)
- In addition to identifying Rtl1 as a novel driver of HCC, our study represents one of the first direct in vivo demonstrations of a role for such a co-opted genetic element in promoting carcinogenesis. (PMID:23593033)
- The results of this study suggest that hyperactive retrotransposition of L1 in neurons triggered by environmental and/or genetic risk factors may contribute to the susceptibility and pathophysiology of schizophrenia. (PMID:24389010)
- Data suggest that DNA is differentially methylated (hypomethylated) at a gene locus associated with regulation of expression of RTL1 and miR136 in type 1 diabetes; these studies were conducted using tissue bank placentas and whole blood cell DNA from children with type 1 diabetes. (RTL1 = retrotransposon-like protein 1; miR136 = microRNA 136) (PMID:27174469)
- We find that placental expression of DIO3 and RTL1) correlates with prenatal growth. Combined, these findings suggest that epigenetic programming and gene expression within the DLK1-DIO3 imprinted domain influence both prenatal and postnatal growth. (PMID:28502757)
- The role of eutherian-specific RTL1 in the nervous system and its implications for the Kagami-Ogata and Temple syndromes. (PMID:33484574)
- Expression profiling of RTL1 in human breast cancer tissues and cell lines. (PMID:34087231)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000109342 | |
| mus_musculus | Peg10 | ENSMUSG00000092035 |
Paralogs (10): RTL8C (ENSG00000134590), RTL3 (ENSG00000179300), LDOC1 (ENSG00000182195), RTL4 (ENSG00000187823), RTL6 (ENSG00000188636), RTL8A (ENSG00000203950), RTL8B (ENSG00000212747), RTL10 (ENSG00000215012), PEG10 (ENSG00000242265), RTL5 (ENSG00000242732)
Protein
Protein identifiers
Retrotransposon-like protein 1 — A6NKG5 (reviewed: A6NKG5)
Alternative names: Mammalian retrotransposon derived protein 1, Paternally expressed gene 11 protein, Retrotransposon-derived protein PEG11
All UniProt accessions (1): A6NKG5
UniProt curated annotations — full annotation on UniProt →
Function. Plays an essential role in capillaries endothelial cells for the maintenance of feto-maternal interface and for development of the placenta.
Subcellular location. Membrane.
Miscellaneous. Rtl1 is one of at least 11 genes called Mar or Mart related to long terminal repeat retrotransposons. They do not correspond to functional retrotransposons, but rather to neofunctionalized retrotransposons genes. RTL1 is an imprinted gene located in a cluster of imprinted genes on chromosome 14. It is expressed from the paternal chromosome and has an antisense transcript with full complementarity to RTL1, RTL1as, expressed from the maternal chromosome, which acts as a repressor for RTL1. Excessive RTL1 expression and decreased RTL1 expression are relevant to upd(14)pat-like and upd(14)mat-like phenotypes, respectively. Paternal and maternal uniparental disomy for chromosome 14 (upd(14)pat and upd(14)mat) cause distinct phenotypes; Upd(14)pat results in a unique phenotype characterized by facial abnormality, a small, bell-shaped thorax and abdominal wall defects, and upd(14)mat leads to pre- and postnatal growth failure and early onset of puberty.
RefSeq proteins (2): NP_001128360, NP_001412214 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021109 | Peptidase_aspartic_dom_sf | Homologous_superfamily |
| IPR032549 | RTL1/1-8/LDOC_capsid-like | Domain |
| IPR032567 | RTL1-rel | Family |
| IPR041577 | RT_RNaseH_2 | Domain |
| IPR043128 | Rev_trsase/Diguanyl_cyclase | Homologous_superfamily |
| IPR043502 | DNA/RNA_pol_sf | Homologous_superfamily |
Pfam: PF16297, PF17919
UniProt features (15 total): compositionally biased region 7, region of interest 4, transmembrane region 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NKG5-F1 | 58.74 | 0.11 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 399 (showing top):
GOBP_MUSCLE_TISSUE_DEVELOPMENT, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT, GOBP_PLACENTA_DEVELOPMENT, chr14q32, HP_INGUINAL_HERNIA, HP_CRYPTORCHIDISM, HP_TALL_STATURE, HP_ABNORMALITY_OF_THE_TONGUE, HP_MACROGLOSSIA, HP_ABNORMAL_LIP_MORPHOLOGY, HP_NARROW_MOUTH, HP_ABNORMAL_UVULA_MORPHOLOGY, HP_ABNORMAL_PALATE_MORPHOLOGY, HP_ABNORMAL_UPPER_LIP_MORPHOLOGY
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
784 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RTL1 | DLK1 | P15803 | 917 |
| RTL1 | DIO3 | P55073 | 791 |
| RTL1 | RTL4 | Q6ZR62 | 628 |
| RTL1 | TP53 | P04637 | 613 |
| RTL1 | RTL6 | Q6ICC9 | 597 |
| RTL1 | BEGAIN | Q9BUH8 | 596 |
| RTL1 | GRB10 | Q13322 | 507 |
| RTL1 | NAP1L5 | Q96NT1 | 498 |
| RTL1 | PEG3 | P78418 | 479 |
| RTL1 | TMC6 | Q7Z403 | 448 |
| RTL1 | MEST | Q5EB52 | 441 |
| RTL1 | WDR20 | Q8TBZ3 | 439 |
| RTL1 | IGF2 | P01344 | 437 |
| RTL1 | SGCE | O43556 | 436 |
| RTL1 | PLAGL1 | Q9UM63 | 434 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APP | RTL1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS), RTL1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B7P3V8, A4FUB7, A4H7G5, A4HVU6, A6NKG5, B4NSS9, B6EU02, F4I1N8, H2KZW3, O10318, O13329, P04586, P0C2J7, P18475, P34601, P47024, Q01577, Q05101, Q09178, Q09293, Q1L6Q1, Q3S4A7, Q4DCH3, Q4QFY1, Q4R6I1, Q52QI2, Q57X81, Q5RBK0, Q5RDX4, Q62120, Q66H30, Q6R2W3, Q7KLI1, Q7LHG5, Q8CDM1, Q8K259, Q8N157, Q90179, Q91829, Q99315
Diamond homologs: A6NKG5, A6ZKI3, O95751, Q17QF6, Q17RB0, Q1JQ94, Q52QI2, Q5DTZ0, Q5HYW3, Q6SEH4, Q6SEH5, Q7M732, Q7TPY9, Q9BWD3, Q505G4, Q6ICC9, Q7TN75, Q86TG7, Q8N8U3, A1Z651, O92815, P03355, P03356, P03358, P03359, P03360, P04026, P04584, P04589, P05895, P08361, P10272, P10273, P10400, P11227, P16103, P16901, P17757, P18042, P18096
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
219 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 181 |
| Likely benign | 28 |
| Benign | 7 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
397 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:100892973:GGTT:G | donor_gain | 0.7900 |
| 14:100892970:C:T | donor_gain | 0.7100 |
| 14:100893799:GAAGA:G | acceptor_gain | 0.7000 |
| 14:100893281:GCCT:G | donor_gain | 0.6800 |
| 14:100893139:G:GT | donor_gain | 0.6700 |
| 14:100892975:TTTA:T | donor_gain | 0.6600 |
| 14:100893580:A:AG | acceptor_gain | 0.6400 |
| 14:100893581:G:GG | acceptor_gain | 0.6400 |
| 14:100893758:A:G | acceptor_gain | 0.6400 |
| 14:100893799:GAA:G | acceptor_gain | 0.6400 |
| 14:100892969:G:GT | donor_gain | 0.6300 |
| 14:100893321:GAC:G | acceptor_gain | 0.6300 |
| 14:100893141:GGTC:G | donor_gain | 0.6200 |
| 14:100893798:A:AG | acceptor_gain | 0.6200 |
| 14:100893799:G:GG | acceptor_gain | 0.6200 |
| 14:100893134:GA:G | donor_gain | 0.6000 |
| 14:100893791:A:AG | acceptor_gain | 0.6000 |
| 14:100893142:GTC:G | donor_gain | 0.5900 |
| 14:100893143:TCT:T | donor_gain | 0.5900 |
| 14:100893144:CTC:C | donor_gain | 0.5900 |
| 14:100893748:A:AG | acceptor_gain | 0.5900 |
| 14:100893140:GGGTC:G | donor_gain | 0.5800 |
| 14:100893320:A:AG | acceptor_gain | 0.5800 |
| 14:100893321:G:GG | acceptor_gain | 0.5800 |
| 14:100893728:TTACA:T | acceptor_loss | 0.5700 |
| 14:100893729:TACAG:T | acceptor_loss | 0.5700 |
| 14:100893730:ACAGG:A | acceptor_loss | 0.5700 |
| 14:100893731:CAGG:C | acceptor_loss | 0.5700 |
| 14:100893732:AGGTT:A | acceptor_loss | 0.5700 |
| 14:100893733:GGTT:G | acceptor_loss | 0.5700 |
AlphaMissense
8929 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:100883267:A:G | W508R | 0.997 |
| 14:100883267:A:T | W508R | 0.997 |
| 14:100881989:A:G | W934R | 0.995 |
| 14:100881989:A:T | W934R | 0.995 |
| 14:100883092:A:G | F566S | 0.995 |
| 14:100884141:G:C | F216L | 0.995 |
| 14:100884141:G:T | F216L | 0.995 |
| 14:100884143:A:G | F216L | 0.995 |
| 14:100883104:A:G | L562P | 0.994 |
| 14:100883461:G:T | A443D | 0.994 |
| 14:100881858:G:C | F977L | 0.993 |
| 14:100881858:G:T | F977L | 0.993 |
| 14:100881860:A:G | F977L | 0.993 |
| 14:100883091:A:C | F566L | 0.993 |
| 14:100883091:A:T | F566L | 0.993 |
| 14:100883093:A:G | F566L | 0.993 |
| 14:100883199:G:C | C530W | 0.993 |
| 14:100883840:A:G | W317R | 0.993 |
| 14:100883840:A:T | W317R | 0.993 |
| 14:100882066:C:G | R908P | 0.992 |
| 14:100882531:A:G | L753P | 0.992 |
| 14:100882792:A:G | L666P | 0.992 |
| 14:100883201:A:G | C530R | 0.992 |
| 14:100883800:A:G | L330P | 0.992 |
| 14:100882485:G:C | S768R | 0.991 |
| 14:100882485:G:T | S768R | 0.991 |
| 14:100882487:T:G | S768R | 0.991 |
| 14:100882630:A:G | L720P | 0.991 |
| 14:100883049:G:C | S580R | 0.991 |
| 14:100883049:G:T | S580R | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000122182 (14:100898196 A>G,T), RS1000212566 (14:100885599 C>T), RS1000267233 (14:100880894 T>A), RS1000294360 (14:100896900 A>AT), RS1000317571 (14:100881905 G>A), RS1000568738 (14:100901868 C>G), RS1000583179 (14:100902051 C>A,T), RS1000684754 (14:100900466 T>C), RS1000912587 (14:100895758 G>T), RS1000984978 (14:100892159 C>A,G), RS1001116800 (14:100896917 C>G,T), RS1001528489 (14:100897047 T>C), RS1001641390 (14:100892427 C>T), RS1001789254 (14:100899279 G>A), RS1001961204 (14:100901214 C>T)
Disease associations
OMIM: gene MIM:611896 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
169 total (30 of 169 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000023 | Inguinal hernia |
| HP:0000028 | Cryptorchidism |
| HP:0000119 | Abnormality of the genitourinary system |
| HP:0000126 | Hydronephrosis |
| HP:0000158 | Macroglossia |
| HP:0000160 | Narrow mouth |
| HP:0000175 | Cleft palate |
| HP:0000193 | Bifid uvula |
| HP:0000194 | Open mouth |
| HP:0000218 | High palate |
| HP:0000252 | Microcephaly |
| HP:0000260 | Wide anterior fontanel |
| HP:0000278 | Retrognathia |
| HP:0000286 | Epicanthus |
| HP:0000293 | Full cheeks |
| HP:0000303 | Mandibular prognathia |
| HP:0000322 | Short philtrum |
| HP:0000327 | Hypoplasia of the maxilla |
| HP:0000337 | Broad forehead |
| HP:0000341 | Narrow forehead |
| HP:0000343 | Long philtrum |
| HP:0000347 | Micrognathia |
| HP:0000358 | Posteriorly rotated ears |
| HP:0000403 | Recurrent otitis media |
| HP:0000431 | Wide nasal bridge |
| HP:0000445 | Wide nose |
| HP:0000463 | Anteverted nares |
| HP:0000470 | Short neck |
| HP:0000490 | Deeply set eye |
| HP:0000565 | Esotropia |
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000539_2 | Type 1 diabetes | 1.000000e-10 |
| GCST003225_29 | Pelvic organ prolapse (moderate/severe) | 3.000000e-07 |
| GCST008477_1 | Emphysema annual change measurement in smokers (adjusted lung density) | 6.000000e-06 |
| GCST008477_19 | Emphysema annual change measurement in smokers (adjusted lung density) | 8.000000e-06 |
| GCST90013405_56 | Liver enzyme levels (alanine transaminase) | 6.000000e-57 |
| GCST90016669_2 | Pancreas volume | 1.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007626 | emphysema imaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | decreases expression | 1 |
| alpha phellandrene | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Chlordan | increases expression | 1 |
| Phenobarbital | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pelvic organ prolapse, type 1 diabetes mellitus